Herbal Medicine Practices of Patients With Liver Cancer in Peru: A Comprehensive Study Toward Integrative Cancer Management Rojas Rojas, Teresa es_PE Bourdy, Geneviève es_PE Ruiz, Eloy es_PE Cerapio, Juan-Pablo es_PE Pineau, Pascal es_PE Gardon, Jacques es_PE Doimi, Franco es_PE Deparis, Xavier es_PE Deharo, Eric es_PE Bertani, Stéphane es_PE 2024-05-30T23:13:38Z 2024-05-30T23:13:38Z 2016-12-08
dc.description The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: TRR was a recipient of a doctoral fellowship from Innóvate Perú (069-FINCyT-BDE-2014); JPC was a recipient of a doctoral fellowship from the Peruvian National Council for Science and Technology (212-2015-FONDECYT); ER and FD were supported by the Young Research Teams Associated with IRD Program (JEAI-INCAncer); and GB, PP, JG, ED, and SB were supported by the Third Cancer Plan of the French National Alliance for Life Sciences and Health (ENV201408).
dc.description.abstract Rationale: The highest burden of liver cancer occurs in developing countries, where the use of herbal medicine (HM) is still widespread. Despite this trend, few studies have been conducted to report HM practices of patients with a hepatic tumor in the developing world. Hence, this study aimed to document the use of HM among patients with liver cancer in Peru.Study design and methods: A comparative behavioral epidemiological survey was conducted among liver cancer patients attending the National Cancer Institute of Peru. Information was obtained by direct interviews based on a semistructured questionnaire. The use of HM in Peruvian liver cancer patients was reported, first, regarding general consumption prior to the onset of disease, and second, after the appearance of symptoms that patients would relate to their tumor. In parallel, general consumption of HM in noncancerous people was assessed as a comparative figure. A correspondence analysis was performed to reveal potential associations between the symptoms of cancer and the specific use of HM.Results: Eighty-eight patients and 117 noncancerous individuals participated in the survey. Overall, 68.3% of the people interviewed claimed to use HM on a regular basis for general health preservation. Furthermore, 56.8% of the patients turned to plants first to treat the disorders for which they later came to the cancer care center. When compared with the number of plant species used routinely (n = 78), a selection of plants was made by patients in response to the symptoms of cancer (n = 46). At least 2 plant species, Aloe vera and Morinda citrifolia, were significantly associated with the treatment of liver cancer-related symptoms in the patient group.Conclusions: The present study is the first survey on the HM practices of patients with liver cancer in Latin America and, more broadly, in the developing world. Our findings confirm that HM remains one of the principal primary health care resources in Peru, even for a severe disease like liver cancer. These traditional, complementary and alternative medicine practices should be taken into consideration in Peruvian health programs aiming to educate the population in cancer prevention and treatment, as well as integrative cancer management.
dc.description.sponsorship Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - Concytec
dc.language.iso eng
dc.publisher SAGE Publications
dc.relation.ispartof Integrative Cancer Therapies
dc.rights info:eu-repo/semantics/openAccess
dc.subject Latin America
dc.subject Indigenous people es_PE
dc.subject cancer es_PE
dc.subject complementary and alternative medicine es_PE
dc.subject developing world es_PE
dc.title Herbal Medicine Practices of Patients With Liver Cancer in Peru: A Comprehensive Study Toward Integrative Cancer Management
dc.type info:eu-repo/semantics/article